BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 016316
(391 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 176 bits (447), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 87/127 (68%), Positives = 98/127 (77%)
Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS 323
R + Q FFDV + DPEV LG LKR++ +EL+ A+ NFS KNILGRGGFG VYKG +
Sbjct: 1 RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
DG LVAVKRLK+ GGE+QFQTEVE IS+AVHRNLLRL GFC T ERLLVYPYM NG
Sbjct: 61 DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 384 SVASRLR 390
SVAS LR
Sbjct: 121 SVASCLR 127
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 172 bits (437), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 84/119 (70%), Positives = 94/119 (78%)
Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK 331
FFDV + DPEV LG LKR++ +EL+ A+ NF KNILGRGGFG VYKG +DG LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
RLK+ GGE+QFQTEVE IS+AVHRNLLRL GFC T ERLLVYPYM NGSVAS LR
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 46/117 (39%), Positives = 65/117 (55%), Gaps = 10/117 (8%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK- 334
EVS ++F EL+ T+NF + N +G GGFG+VYKG + + VAVK+L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAA 64
Query: 335 --DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
D + QF E++ ++ H NL+ L GF S ++ LVY YMPNGS+ RL
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 46/117 (39%), Positives = 65/117 (55%), Gaps = 10/117 (8%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK- 334
EVS ++F EL+ T+NF + N +G GGFG+VYKG + + VAVK+L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAA 64
Query: 335 --DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
D + QF E++ ++ H NL+ L GF S ++ LVY YMPNGS+ RL
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 45/116 (38%), Positives = 64/116 (55%), Gaps = 10/116 (8%)
Query: 283 VSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK-- 334
VS ++F EL+ T+NF + N +G GGFG+VYKG + + VAVK+L
Sbjct: 1 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAM 59
Query: 335 -DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
D + QF E++ ++ H NL+ L GF S ++ LVY YMPNGS+ RL
Sbjct: 60 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 115
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 45/102 (44%), Positives = 62/102 (60%), Gaps = 1/102 (0%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV 349
R +L AT+NF K ++G G FG VYKG DGA VA+KR + + G +F+TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
ET+S H +L+ L GFC NE +L+Y YM NG++ L G
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 45/102 (44%), Positives = 62/102 (60%), Gaps = 1/102 (0%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV 349
R +L AT+NF K ++G G FG VYKG DGA VA+KR + + G +F+TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
ET+S H +L+ L GFC NE +L+Y YM NG++ L G
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 42/108 (38%), Positives = 59/108 (54%), Gaps = 10/108 (9%)
Query: 291 YTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK---DYNIAGG 341
++F EL+ T+NF + N G GGFG+VYKG + + VAVK+L D
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+ QF E++ + H NL+ L GF S ++ LVY Y PNGS+ RL
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 29 AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSG 88
AG Y + +K H N+LE I S R+ T +P + S+ G
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN--RLSTRNP------CNITSRVYGG 619
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXX 148
SP N + + + N + G IP +G + L L+L +N +G IPD +GD
Sbjct: 620 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 679
Query: 149 XXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTF---KVTGNPLICG 204
G P+++S + LT +DLS NNLSG +P++ TF K NP +CG
Sbjct: 680 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 41/122 (33%), Positives = 57/122 (46%)
Query: 71 SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130
+P + L L + +G + P + N ++L S+ L N + G IP+SLG L KL+ L L
Sbjct: 388 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 447
Query: 131 NNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
N GEIP L TG P LS +L + LS N L+G +PK
Sbjct: 448 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 191 AR 192
R
Sbjct: 508 GR 509
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 42 KNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQ 101
KN L + Y L+N T P + + CS + +L L LSGT+ +G+L+KL+
Sbjct: 390 KNTLQELY--LQNNGFTGKIPPT--LSNCSE---LVSLHLSFNYLSGTIPSSLGSLSKLR 442
Query: 102 SVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGS 161
+ L N + G IP L ++ L+TL L N TGEIP L + TG
Sbjct: 443 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 502
Query: 162 CPESLSKIESLTLVDLSYNNLSGSLP 187
P+ + ++E+L ++ LS N+ SG++P
Sbjct: 503 IPKWIGRLENLAILKLSNNSFSGNIP 528
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 52/113 (46%), Gaps = 27/113 (23%)
Query: 86 LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDX 145
L+G + + N T L + L NN + G IP +G+LE L L LSNN F+G IP LGD
Sbjct: 475 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD- 533
Query: 146 XXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
SL +DL+ N +G++P A FK +G
Sbjct: 534 -----------------------CRSLIWLDLNTNLFNGTIP---AAMFKQSG 560
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 42/136 (30%), Positives = 59/136 (43%), Gaps = 28/136 (20%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L + LSG S I T+L+ + + +N +GPIP L+ LQ L L+ NKFTGEI
Sbjct: 225 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 282
Query: 139 PDSL-------------------------GDXXXXXXXXXXXXXXTGSCP-ESLSKIESL 172
PD L G +G P ++L K+ L
Sbjct: 283 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 342
Query: 173 TLVDLSYNNLSGSLPK 188
++DLS+N SG LP+
Sbjct: 343 KVLDLSFNEFSGELPE 358
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 38/140 (27%), Positives = 61/140 (43%), Gaps = 28/140 (20%)
Query: 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKF 134
++ L L G + P+ G+ + L+S+ L +N G +P +L K+ L+ LDLS N+F
Sbjct: 293 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 352
Query: 135 TGEIPDSLGDXXXXXXXXXXXXXX---------------------------TGSCPESLS 167
+GE+P+SL + TG P +LS
Sbjct: 353 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 412
Query: 168 KIESLTLVDLSYNNLSGSLP 187
L + LS+N LSG++P
Sbjct: 413 NCSELVSLHLSFNYLSGTIP 432
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXX 151
P++G+ + LQ + + N + G ++ +L+ L++S+N+F G IP
Sbjct: 214 PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYL 271
Query: 152 XXXXXXXTGSCPESLS-KIESLTLVDLSYNNLSGSLP 187
TG P+ LS ++LT +DLS N+ G++P
Sbjct: 272 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 308
Score = 32.7 bits (73), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSP- 92
E+ L++ K+ L D N+L +W ++ +PC++ +TC D V+++ L S+ L+ S
Sbjct: 10 EIHQLISFKDVLPDK-NLLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAV 66
Query: 93 --WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXX 150
+ +LT L+S+ L N+ I G + + L +LDLS N +G +
Sbjct: 67 SSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 125
Query: 151 XXXXXXXXTGSCPESLS---KIESLTLVDLSYNNLSGS 185
T P +S K+ SL ++DLS N++SG+
Sbjct: 126 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 163
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 29 AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSG 88
AG Y + +K H N+LE I S R+ T +P + S+ G
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ--LNRLSTRNP------CNITSRVYGG 622
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXX 148
SP N + + + N + G IP +G + L L+L +N +G IPD +GD
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 149 XXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTF---KVTGNPLICG 204
G P+++S + LT +DLS NNLSG +P++ TF K NP +CG
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 41/122 (33%), Positives = 57/122 (46%)
Query: 71 SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130
+P + L L + +G + P + N ++L S+ L N + G IP+SLG L KL+ L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 131 NNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
N GEIP L TG P LS +L + LS N L+G +PK
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 191 AR 192
R
Sbjct: 511 GR 512
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 42 KNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQ 101
KN L + Y L+N T P + + CS + +L L LSGT+ +G+L+KL+
Sbjct: 393 KNTLQELY--LQNNGFTGKIPPT--LSNCS---ELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 102 SVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGS 161
+ L N + G IP L ++ L+TL L N TGEIP L + TG
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 162 CPESLSKIESLTLVDLSYNNLSGSLP 187
P+ + ++E+L ++ LS N+ SG++P
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIP 531
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 52/113 (46%), Gaps = 27/113 (23%)
Query: 86 LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDX 145
L+G + + N T L + L NN + G IP +G+LE L L LSNN F+G IP LGD
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD- 536
Query: 146 XXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
SL +DL+ N +G++P A FK +G
Sbjct: 537 -----------------------CRSLIWLDLNTNLFNGTIP---AAMFKQSG 563
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 42/136 (30%), Positives = 59/136 (43%), Gaps = 28/136 (20%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L + LSG S I T+L+ + + +N +GPIP L+ LQ L L+ NKFTGEI
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285
Query: 139 PDSL-------------------------GDXXXXXXXXXXXXXXTGSCP-ESLSKIESL 172
PD L G +G P ++L K+ L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 173 TLVDLSYNNLSGSLPK 188
++DLS+N SG LP+
Sbjct: 346 KVLDLSFNEFSGELPE 361
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 38/140 (27%), Positives = 61/140 (43%), Gaps = 28/140 (20%)
Query: 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKF 134
++ L L G + P+ G+ + L+S+ L +N G +P +L K+ L+ LDLS N+F
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 135 TGEIPDSLGDXXXXXXXXXXXXXX---------------------------TGSCPESLS 167
+GE+P+SL + TG P +LS
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 168 KIESLTLVDLSYNNLSGSLP 187
L + LS+N LSG++P
Sbjct: 416 NCSELVSLHLSFNYLSGTIP 435
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXX 151
P++G+ + LQ + + N + G ++ +L+ L++S+N+F G IP
Sbjct: 217 PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYL 274
Query: 152 XXXXXXXTGSCPESLS-KIESLTLVDLSYNNLSGSLP 187
TG P+ LS ++LT +DLS N+ G++P
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Score = 32.3 bits (72), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSP- 92
E+ L++ K+ L D N+L +W ++ +PC++ +TC D V+++ L S+ L+ S
Sbjct: 13 EIHQLISFKDVLPD-KNLLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAV 69
Query: 93 --WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXX 150
+ +LT L+S+ L N+ I G + + L +LDLS N +G +
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 151 XXXXXXXXTGSCPESLS---KIESLTLVDLSYNNLSGS 185
T P +S K+ SL ++DLS N++SG+
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 17/121 (14%)
Query: 276 NDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CF-----SDGALVA 329
N QY + + H+KR + K LG G FG V+ C D LVA
Sbjct: 26 NPQYFSDACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVA 75
Query: 330 VKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
VK LK+ + + + FQ E E +++ H++++R G C+ L+V+ YM +G + L
Sbjct: 76 VKALKEASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 390 R 390
R
Sbjct: 135 R 135
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 17/115 (14%)
Query: 283 VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDY 336
+ + H+KR + K LG G FG V+ C++ D LVAVK LKD
Sbjct: 7 IHVQHIKR----------RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP 56
Query: 337 NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
+A + FQ E E ++ H ++++ G C + ++V+ YM +G + LR
Sbjct: 57 TLAARK-DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA 110
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G +G VY G + +L VAVK LK+ + E F E + H N
Sbjct: 32 TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 89
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L++L G C+ E +V YMP G++ LR
Sbjct: 90 LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLR 120
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKG-CF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V+ C D LVAVK LK+ + + + FQ E E +++ H++++R
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G C+ L+V+ YM +G + LR
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFLR 112
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 35/188 (18%)
Query: 37 ALVAVKNNLHDPYNVLENWDITSVDPC--SWRMITCSPDGY--------VSALGLPS--- 83
AL+ +K +L +P L +W + + D C +W + C D +S L LP
Sbjct: 10 ALLQIKKDLGNP-TTLSSW-LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67
Query: 84 -------------------QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
+L G + P I LT+L + + + + G IP L +++ L
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 125 QTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESL-TLVDLSYNNLS 183
TLD S N +G +P S+ +G+ P+S L T + +S N L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 184 GSLPKISA 191
G +P A
Sbjct: 188 GKIPPTFA 195
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 18/46 (39%), Positives = 27/46 (58%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139
+G L + L+NN I G +P L +L+ L +L++S N GEIP
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKG-CF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V+ C D LVAVK LK+ + + + FQ E E +++ H++++R
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 78
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G C+ L+V+ YM +G + LR
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFLR 106
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 123
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 54 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 142
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 41 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 129
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 122
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 55 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 143
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 125
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 125
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 122
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 28 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 88 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 116
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 119
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 307 NILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G +DG + AVK L G QF TE + H N+L
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLR 390
L G C +E L+V PYM +G + + +R
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 123
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 17/111 (15%)
Query: 287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAG 340
H+KR+ N K LG G FG V+ C++ D LVAVK LKD +
Sbjct: 9 HIKRH----------NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DN 57
Query: 341 GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
F E E ++ H ++++ G C + ++V+ YM +G + LR
Sbjct: 58 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA 108
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G FG VY+G + +L VAVK LK+ + E F E + H N
Sbjct: 11 TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L++L G C+ E ++ +M G++ LR
Sbjct: 69 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR 99
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQ 344
GH+ + + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E
Sbjct: 1 GHMSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-- 57
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + H NL++L G C+ E ++ +M G++ LR
Sbjct: 58 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 103
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR 106
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 63
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR 102
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 20/140 (14%)
Query: 255 IVVGLLVWLRY---RHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGR 311
+ GL+ L Y + N+ + V+ YD + ++ + K+ LG
Sbjct: 185 VADGLITTLHYPAPKRNKPTIYGVSPNYD--------------KWEMERTDITMKHKLGG 230
Query: 312 GGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
G +G VY+G + +L VAVK LK+ + E F E + H NL++L G C+ E
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCTRE 288
Query: 371 NERLLVYPYMPNGSVASRLR 390
++ +M G++ LR
Sbjct: 289 PPFYIITEFMTYGNLLDYLR 308
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQ 344
GH+ + + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E
Sbjct: 1 GHMSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-- 57
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + H NL++L G C+ E ++ +M G++ LR
Sbjct: 58 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 103
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR 101
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAV 356
++ ++++G G FG V K L A+KR+K+Y F E+E + L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N++ L G C L Y P+G++ LR
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 66
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 105
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
++++G G FG V K L A+KR+K+Y F E+E + L H N++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C L Y P+G++ LR
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLR 108
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 63
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 102
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E + H N
Sbjct: 11 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L++L G C+ E ++ +M G++ LR
Sbjct: 69 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLR 99
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ 105
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 64
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 103
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
++++G G FG V K L A+KR+K+Y F E+E + L H N++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C L Y P+G++ LR
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLR 115
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR 101
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 304 SAKNILGRGGFGIVYKGCFSDGA-----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
+ + ++G G FG VYKG + VA+K LK V F E + H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N++RL G S +++ YM NG++ LR
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 18 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 75
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 76 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 114
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ 105
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVET 351
+ + ++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H NL++L G C+ E ++ +M G++ LR
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G +G VY+G + +L VAVK LK+ + E F E + H N
Sbjct: 11 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L++L G C+ E ++ +M G++ LR
Sbjct: 69 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR 99
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 20/140 (14%)
Query: 255 IVVGLLVWLRY---RHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGR 311
+ GL+ L Y + N+ + V+ YD + ++ + K+ LG
Sbjct: 224 VADGLITTLHYPAPKRNKPTVYGVSPNYD--------------KWEMERTDITMKHKLGG 269
Query: 312 GGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
G +G VY+G + +L VAVK LK+ + E F E + H NL++L G C+ E
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCTRE 327
Query: 371 NERLLVYPYMPNGSVASRLR 390
++ +M G++ LR
Sbjct: 328 PPFYIITEFMTYGNLLDYLR 347
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 20/140 (14%)
Query: 255 IVVGLLVWLRY---RHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGR 311
+ GL+ L Y + N+ + V+ YD + ++ + K+ LG
Sbjct: 182 VADGLITTLHYPAPKRNKPTVYGVSPNYD--------------KWEMERTDITMKHKLGG 227
Query: 312 GGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
G +G VY+G + +L VAVK LK+ + E F E + H NL++L G C+ E
Sbjct: 228 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCTRE 285
Query: 371 NERLLVYPYMPNGSVASRLR 390
++ +M G++ LR
Sbjct: 286 PPFYIITEFMTYGNLLDYLR 305
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VAVK +K+ +++ E +F E +T+ H L++ G CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 369 TENERLLVYPYMPNGSVASRLR 390
E +V Y+ NG + + LR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR 95
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 44/95 (46%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ 100
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
+++S F LG G + VYKG + G VA+K +K + G E+ +
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPN 382
H N++RL TEN+ LV+ +M N
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN 87
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 51/115 (44%), Gaps = 4/115 (3%)
Query: 280 DPEVSLG-HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYN 337
+PE L K K+ + A +F LG+G FG VY + A+K L
Sbjct: 12 NPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ 71
Query: 338 I--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ AG E Q + EVE S H N+LRL G+ L+ Y P G+V L+
Sbjct: 72 LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 51/115 (44%), Gaps = 4/115 (3%)
Query: 280 DPEVSLG-HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYN 337
+PE L K K+ + A +F LG+G FG VY + A+K L
Sbjct: 12 NPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ 71
Query: 338 I--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ AG E Q + EVE S H N+LRL G+ L+ Y P G+V L+
Sbjct: 72 LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 1 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 61 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR 111
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR 111
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 3 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 63 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 102
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 3 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 63 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 102
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
K+ + A +F LG+G FG VY + A+K L + AG E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
S H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 75 KQRPIFIITEYMANGCLLNYLR 96
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 81 KQRPIFIITEYMANGCLLNYLR 102
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 74 KQRPIFIITEYMANGCLLNYLR 95
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 51/115 (44%), Gaps = 4/115 (3%)
Query: 280 DPEVSLG-HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYN 337
+PE L K K+ + A +F LG+G FG VY + A+K L
Sbjct: 3 NPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ 62
Query: 338 I--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ AG E Q + EVE S H N+LRL G+ L+ Y P G+V L+
Sbjct: 63 LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 117
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 75 KQRPIFIITEYMANGCLLNYLR 96
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 99
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ ++ YM NG + + LR
Sbjct: 70 KQRPIFIITEYMANGCLLNYLR 91
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
A +F LG+G FG VY + A+K L + AG E Q + EVE S
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
H N+LRL G+ L+ Y P G+V L+
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 97
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 45/82 (54%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +K+ +++ E F E E + H L++L G C
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ LV+ +M +G ++ LR
Sbjct: 93 EQAPICLVFEFMEHGCLSDYLR 114
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 3/93 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
+F LG+G FG VY + A+K L + AG E Q + EVE S H
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N+LRL G+ L+ Y P G+V L+
Sbjct: 72 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 3/93 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
+F LG+G FG VY + A+K L + AG E Q + EVE S H
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N+LRL G+ L+ Y P G+V L+
Sbjct: 72 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 10/125 (8%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
+ F D + DP ++ KEL A +N S ++G G FG V G
Sbjct: 20 RTFVDPHTYEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K LK F E + H N++RL G + ++V YM NGS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLR 390
S LR
Sbjct: 134 DSFLR 138
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +++ A E F E E + H L++L G C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ LV+ +M +G ++ LR
Sbjct: 73 EQAPICLVFEFMEHGCLSDYLR 94
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +++ A E F E E + H L++L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ LV+ +M +G ++ LR
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLR 92
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +++ A E F E E + H L++L G C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ LV+ +M +G ++ LR
Sbjct: 73 EQAPICLVFEFMEHGCLSDYLR 94
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +++ A E F E E + H L++L G C
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ LV+ +M +G ++ LR
Sbjct: 76 EQAPICLVFEFMEHGCLSDYLR 97
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL------KDYNIAGGEVQFQTEVET 351
A + + +G+GGFG+V+KG D ++VA+K L + + +FQ EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+S H N+++L G N +V ++P G + RL
Sbjct: 77 MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRL 112
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL------KDYNIAGGEVQFQTEVET 351
A + + +G+GGFG+V+KG D ++VA+K L + + +FQ EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+S H N+++L G N +V ++P G + RL
Sbjct: 77 MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRL 112
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 1/83 (1%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+GRG FG V+ G +D LVAVK ++ + +F E + H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 368 STENERLLVYPYMPNGSVASRLR 390
+ + +V + G + LR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR 204
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL------KDYNIAGGEVQFQTEVET 351
A + + +G+GGFG+V+KG D ++VA+K L + + +FQ EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+S H N+++L G N +V ++P G + RL
Sbjct: 77 MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRL 112
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 1/83 (1%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+GRG FG V+ G +D LVAVK ++ + +F E + H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 368 STENERLLVYPYMPNGSVASRLR 390
+ + +V + G + LR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR 204
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G G FG V++ + +VAVK LK+ A + FQ E ++ + N+++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C+ L++ YM G + LR
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 10/125 (8%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
+ F D + DP ++ KEL A +N S ++G G FG V G
Sbjct: 20 RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K LK F E + H N++RL G + ++V YM NGS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLR 390
S LR
Sbjct: 134 DSFLR 138
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 10/125 (8%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
+ F D + DP ++ KEL A +N S ++G G FG V G
Sbjct: 20 RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K LK F E + H N++RL G + ++V YM NGS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLR 390
S LR
Sbjct: 134 DSFLR 138
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 10/125 (8%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
+ F D + DP ++ KEL A +N S ++G G FG V G
Sbjct: 20 RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K LK F E + H N++RL G + ++V YM NGS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLR 390
S LR
Sbjct: 134 DSFLR 138
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 52/125 (41%), Gaps = 10/125 (8%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
+ F D + DP ++ KEL A +N S ++G G FG V G
Sbjct: 20 RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K LK F E + H N++RL G + ++V YM NGS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLR 390
S LR
Sbjct: 134 DSFLR 138
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 28 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V YM NGS+ S LR
Sbjct: 86 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 126
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V YM NGS+ S LR
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 16/147 (10%)
Query: 255 IVVGLLVWLRYRHNQQI-----FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNIL 309
+V+ L V+ R R+N ++ + VN +Y + Y E A + L
Sbjct: 1 LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADV-----YVPDEWEVAREKITMSREL 55
Query: 310 GRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
G+G FG+VY KG D VA+K + + ++F E + +++RL
Sbjct: 56 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 115
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLR 390
G S L++ M G + S LR
Sbjct: 116 LGVVSQGQPTLVIMELMTRGDLKSYLR 142
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 38 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V YM NGS+ S LR
Sbjct: 96 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 136
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 11 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V YM NGS+ S LR
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 109
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V YM NGS+ S LR
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 6/82 (7%)
Query: 307 NILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+LG G FG VYKG + +G V A+K L + V+F E ++ H +L+
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 362 RLCGFCSTENERLLVYPYMPNG 383
RL G C + + LV MP+G
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHG 124
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 6/82 (7%)
Query: 307 NILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+LG G FG VYKG + +G V A+K L + V+F E ++ H +L+
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 362 RLCGFCSTENERLLVYPYMPNG 383
RL G C + + LV MP+G
Sbjct: 81 RLLGVCLSPTIQ-LVTQLMPHG 101
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 10/91 (10%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 21 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRG 391
G C + R L+ Y+P GS+ L+
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA 109
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 16 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 103
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 17 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 104
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 21 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 108
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 49 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 18 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 23 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 110
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 303 FSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNL 360
+ +G GGF V C G +VA+K + D N G ++ + +TE+E + H+++
Sbjct: 12 YELHETIGTGGFAKVKLACHILTGEMVAIK-IMDKNTLGSDLPRIKTEIEALKNLRHQHI 70
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV 385
+L T N+ +V Y P G +
Sbjct: 71 CQLYHVLETANKIFMVLEYCPGGEL 95
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 18 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG G FG V C+ G +VAVK LK+ +Q E+E + H ++++
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRL 389
G C + E+ LV Y+P GS+ L
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 19 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 106
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 25 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 83 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 112
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 24 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 111
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 22 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 109
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG G FG V C+ G +VAVK LK+ +Q E+E + H ++++
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRL 389
G C + E+ LV Y+P GS+ L
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 18 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 2/82 (2%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +++ A E F E E + H L++L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 369 TENERLLVYPYMPNGSVASRLR 390
+ LV +M +G ++ LR
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR 95
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 36 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 123
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 36 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ Y+P GS+ L+
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 123
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 72 --HCNIVRLRYFFYSSGEK 88
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 17 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 72
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 73 --HCNIVRLRYFFYSSGEK 89
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 29 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 84
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 85 --HCNIVRLRYFFYSSGEK 101
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 35 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 90
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 91 --HCNIVRLRYFFYSSGEK 107
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 72 --HCNIVRLRYFFYSSGEK 88
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 72 --HCNIVRLRYFFYSSGEK 88
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 72 --HCNIVRLRYFFYSSGEK 88
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 24 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 79
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 80 --HCNIVRLRYFFYSSGEK 96
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 28 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 83
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 84 --HCNIVRLRYFFYSSGEK 100
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 20 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 75
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 76 --HCNIVRLRYFFYSSGEK 92
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 28 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 83
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 84 --HCNIVRLRYFFYSSGEK 100
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 21 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 76
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 77 --HCNIVRLRYFFYSSGEK 93
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 4/94 (4%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLK---DYNIAGGEVQFQTEVETISLAVH 357
+ + + I+G GGFG VY+ F G VAVK + D +I+ + E + ++ H
Sbjct: 7 AELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
N++ L G C E LV + G + L G
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG 99
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 14/94 (14%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 44 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 99
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPN 382
H N++RL F + E+ LV Y+P
Sbjct: 100 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 131
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 14/94 (14%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 105
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPN 382
H N++RL F + E+ LV Y+P
Sbjct: 106 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 14/94 (14%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 105
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPN 382
H N++RL F + E+ LV Y+P
Sbjct: 106 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 52 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 107
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 108 --HCNIVRLRYFFYSSGEK 124
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 14/94 (14%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 54 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 109
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPN 382
H N++RL F + E+ LV Y+P
Sbjct: 110 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 141
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ D G LVA+K+ L+D E+Q +++
Sbjct: 95 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 150
Query: 355 AVHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 151 --HCNIVRLRYFFYSSGEK 167
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 5/77 (6%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKD--YNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
LG+G +GIV+K G +VAVK++ D N + F+ + L+ H N++ L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 366 FCSTENER--LLVYPYM 380
+N+R LV+ YM
Sbjct: 77 VLRADNDRDVYLVFDYM 93
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
LG G FG V+ G +++ VAVK LK ++ VQ F E + H L+RL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 368 STENERLLVYPYMPNGSVASRLR 390
+ E ++ YM GS+ L+
Sbjct: 78 TREEPIYIITEYMAKGSLLDFLK 100
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 31/79 (39%), Positives = 43/79 (54%), Gaps = 12/79 (15%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHR 358
+F K++LG G G IVY+G F D VAVKR+ + ++ A EVQ E + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRESDE-----HP 78
Query: 359 NLLRLCGFCSTENERLLVY 377
N++R FC TE +R Y
Sbjct: 79 NVIRY--FC-TEKDRQFQY 94
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQ 344
Y E + + LG+G FG+VY+G D VAVK + + ++
Sbjct: 7 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L+V M +G + S LR
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 48/114 (42%), Gaps = 14/114 (12%)
Query: 291 YTFKELRAATSNFSA---KNI-----LGRGGFGIVYKGCFS------DGALVAVKRLKDY 336
Y+F ++ S+ KNI LG G FG VY+G S VAVK L +
Sbjct: 13 YSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 72
Query: 337 NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
E+ F E IS H+N++R G R ++ M G + S LR
Sbjct: 73 CSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 126
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFL 88
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFL 88
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLR 132
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 41/149 (27%), Positives = 59/149 (39%), Gaps = 24/149 (16%)
Query: 266 RHNQQIFFDVNDQYDPEVSLGHLK----------RYTFKELRAATSNFSA---KNI---- 308
R +Q++ + PE L L+ Y+F ++ S+ KNI
Sbjct: 4 RKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIR 63
Query: 309 -LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
LG G FG VY+G S VAVK L + E+ F E IS H+N++
Sbjct: 64 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
R G R ++ M G + S LR
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLR 152
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLR 140
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLR 140
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLR 126
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL 85
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLR 142
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLR 125
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLR 126
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQ 344
Y E + + LG+G FG+VY+G D VAVK + + ++
Sbjct: 8 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L+V M +G + S LR
Sbjct: 68 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR 113
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG V + C D G +VAVK+L+ ++ F+ E+E + H N+++
Sbjct: 21 LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLR 390
G C + R L+ ++P GS+ L+
Sbjct: 79 YKGVCYSAGRRNLKLIMEFLPYGSLREYLQ 108
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQ 344
Y E + + LG+G FG+VY+G D VAVK + + ++
Sbjct: 7 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L+V M +G + S LR
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLR 140
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLR 166
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLR 117
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLR 125
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G D VAVK + + ++F E + +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G S L+V M +G + S LR
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VY+G S VAVK L + E+ F E IS H+N++R
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
G R ++ M G + S LR
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLR 143
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 36/125 (28%), Positives = 51/125 (40%), Gaps = 10/125 (8%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
+ F D + DP ++ KEL A +N S ++G G FG V G
Sbjct: 20 RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K LK F E + H N++RL G + ++V M NGS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 386 ASRLR 390
S LR
Sbjct: 134 DSFLR 138
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G D VAVK + + ++F E + +++R
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G S L+V M +G + S LR
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLR 109
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G D VAVK + + ++F E + +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G S L+V M +G + S LR
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G D VAVK + + ++F E + +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G S L+V M +G + S LR
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
+ NF +G G +G+VYK G +VA+K+++ D G E+ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYM 380
H N+++L TEN+ LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHV 87
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 40/92 (43%), Gaps = 3/92 (3%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGA-LVAVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
+F LG+G FG VY +VA+K L I G E Q + E+E + H
Sbjct: 24 DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N+LRL + L+ Y P G + L+
Sbjct: 84 NILRLYNYFYDRRRIYLILEYAPRGELYKELQ 115
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK N++ F E + + H L++L S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 251 -EEPIYIVTEYMSKGSLLDFLKG 272
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 84 TQEPIYIITEYMENGSLVDFLK 105
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 79
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 80 TQEPIYIITEYMENGSLVDFLK 101
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 85
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 86 TQEPIYIITEYMENGSLVDFLK 107
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 84 TQEPIYIITEYMENGSLVDFLK 105
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+K+++ D G E+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV 83
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK 99
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK 99
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 82
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 83 TQEPIYIITEYMENGSLVDFLK 104
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 86
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 87 TQEPIYIITEYMENGSLVDFLK 108
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G D VAVK + + ++F E + +++R
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G S L+V M +G + S LR
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLR 111
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK 99
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 113
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 87
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 88 TQEPIYIITEYMENGSLVDFLK 109
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLR 102
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 78
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 79 TQEPIYIITEYMENGSLVDFLK 100
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 32/101 (31%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V M NGS+ S LR
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
LG G FG V+ G +++ VAVK LK ++ VQ F E + H L+RL
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 368 STENERLLVYPYMPNGSVASRLR 390
+ E ++ +M GS+ L+
Sbjct: 77 TKEEPIYIITEFMAKGSLLDFLK 99
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 9 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 69 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 114
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 32/101 (31%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A +N S ++G G FG V G VA+K LK F E
Sbjct: 11 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++RL G + ++V M NGS+ S LR
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 109
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 19/116 (16%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKD 335
EV H ++ K +R LG G FG V + C D G VAVK LK
Sbjct: 12 EVDPTHFEKRFLKRIRD----------LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKP 60
Query: 336 YNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVYPYMPNGSVASRL 389
+ + E+E + H N+++ G C+ + N L+ ++P+GS+ L
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLR 102
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 5 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 65 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 110
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 80 LYGVVLTPPMK-MVTELAPLGSLLDRLR 106
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 2 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 62 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 107
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLR 112
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 113
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 28/113 (24%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 291 YTFKELRAATSNFSAK---------NILGRGGFGIVYKGCFS----DGALVAVKRLKDYN 337
+TF++ A F+ + ++G G FG V G VA+K LK
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F +E + H N++ L G + +++ +M NGS+ S LR
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 126
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQ 344
Y E A + LG+G FG+VY KG D VA+K + + ++
Sbjct: 9 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F E + +++RL G S L++ M G + S LR
Sbjct: 69 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 114
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLR 112
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLR 102
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 73
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 74 TQEPIYIITEYMENGSLVDFLK 95
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
LG G FG+V +G + VAVK LK ++ E F EV + HRNL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR 390
L G T + +V P GS+ RLR
Sbjct: 80 LYGVVLTPPMK-MVTELAPLGSLLDRLR 106
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 72
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 73 TQEPIYIITEYMENGSLVDFLK 94
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 76 DNPHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVR 109
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 306 KNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+ ++G G FG V +G + VA+K LK +F +E + H N++
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
RL G + +++ +M NG++ S LR
Sbjct: 81 RLEGVVTNSMPVMILTEFMENGALDSFLR 109
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 306 KNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+ ++G G FG V +G + VA+K LK +F +E + H N++
Sbjct: 19 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
RL G + +++ +M NG++ S LR
Sbjct: 79 RLEGVVTNSMPVMILTEFMENGALDSFLR 107
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 79 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 112
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 79 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 112
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 75 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 108
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 76 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 109
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 78 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 111
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 77 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 110
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 36.2 bits (82), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQFQTE 348
E A + LG+G FG+VY KG D VA+K + + ++F E
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ +++RL G S L++ M G + S LR
Sbjct: 64 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 105
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 36.2 bits (82), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 22/73 (30%), Positives = 36/73 (49%), Gaps = 1/73 (1%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G G +G+VYK S G +VA+KR++ D G E+ + H N++ L
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 368 STENERLLVYPYM 380
+E LV+ +M
Sbjct: 89 HSERCLTLVFEFM 101
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 36.2 bits (82), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 77 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 110
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 36.2 bits (82), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVR 108
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 36.2 bits (82), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 22/73 (30%), Positives = 36/73 (49%), Gaps = 1/73 (1%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G G +G+VYK S G +VA+KR++ D G E+ + H N++ L
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 368 STENERLLVYPYM 380
+E LV+ +M
Sbjct: 89 HSERCLTLVFEFM 101
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 35.8 bits (81), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF 345
G L +KE+ + ++GRG FG+V K + VA+K+++ F
Sbjct: 1 GSLHMIDYKEI-------EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAF 49
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
E+ +S H N+++L G C N LV Y GS+ + L G
Sbjct: 50 IVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG 93
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 35.8 bits (81), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 5/80 (6%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVET 351
+ E+ A+ S + +G G FG VYKG + VAVK LK + + Q F+ EV
Sbjct: 30 YWEIEASEVMLSTR--IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAV 85
Query: 352 ISLAVHRNLLRLCGFCSTEN 371
+ H N+L G+ + +N
Sbjct: 86 LRKTRHVNILLFMGYMTKDN 105
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 77 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 110
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 309 LGRGGFGIV--YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG GGF V +G DG A+KR+ + E + Q E + L H N+LRL +
Sbjct: 37 LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 367 CSTE----NERLLVYPYMPNGSV 385
C E +E L+ P+ G++
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTL 117
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 21 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 81 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 114
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQFQTE 348
E A + LG+G FG+VY KG D VA+K + + ++F E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ +++RL G S L++ M G + S LR
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 107
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVY----KGCFSD--GALVAVKRLKDYNIAGGEVQFQTE 348
E A + LG+G FG+VY KG D VA+K + + ++F E
Sbjct: 10 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ +++RL G S L++ M G + S LR
Sbjct: 70 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 111
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 25 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 85 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 118
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 13/111 (11%)
Query: 292 TFKELRAATSNFSAKNI-----LGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAG 340
FK L F KN+ LG G FG V K + VAVK LK+ N +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASP 67
Query: 341 GEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
E++ +E + H ++++L G CS + LL+ Y GS+ LR
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 77 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 110
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 39/78 (50%), Gaps = 6/78 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
R +++ ++G G FG+VY+ D G LVA+K+ + G+ E++ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 71 DHCNIVRLRYFFYSSGEK 88
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 13/111 (11%)
Query: 292 TFKELRAATSNFSAKNI-----LGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAG 340
FK L F KN+ LG G FG V K + VAVK LK+ N +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASP 67
Query: 341 GEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
E++ +E + H ++++L G CS + LL+ Y GS+ LR
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 39/78 (50%), Gaps = 6/78 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
R +++ ++G G FG+VY+ D G LVA+K+ + G+ E++ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 71 DHCNIVRLRYFFYSSGEK 88
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 78 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 111
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 39/78 (50%), Gaps = 6/78 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
R +++ ++G G FG+VY+ D G LVA+K+ + G+ E++ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENER 373
H N++RL F + E+
Sbjct: 71 DHCNIVRLRYFFYSSGEK 88
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 108
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 13/111 (11%)
Query: 292 TFKELRAATSNFSAKNI-----LGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAG 340
FK L F KN+ LG G FG V K + VAVK LK+ N +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASP 67
Query: 341 GEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
E++ +E + H ++++L G CS + LL+ Y GS+ LR
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 12 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 72 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR 105
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 69 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR 102
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 78 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 111
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 40 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 100 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 133
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 108
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 82 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 115
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 78 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 111
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 35.8 bits (81), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 19/75 (25%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 301 SNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAVH 357
+NF + +GRG F VY+ C DG VA+K+++ +++ + + E++ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 358 RNLLRLCGFCSTENE 372
N+++ +NE
Sbjct: 92 PNVIKYYASFIEDNE 106
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 75 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR 108
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 82 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 115
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+ +++ D G E+ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
NF +G G +G+VYK G +VA+ +++ D G E+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 359 NLLRLCGFCSTENERLLVYPYM 380
N+++L TEN+ LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ ++GRG FG+V K + VA+K+++ F E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNI 63
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++L G C N LV Y GS+ + L G
Sbjct: 64 VKLYGACL--NPVCLVMEYAEGGSLYNVLHG 92
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+K L++ + E ++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 77 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 110
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 9/89 (10%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V + C D G VAVK LK + + E+E + H N+++
Sbjct: 17 LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 363 LCGFCSTE--NERLLVYPYMPNGSVASRL 389
G C+ + N L+ ++P+GS+ L
Sbjct: 76 YKGICTEDGGNGIKLIMEFLPSGSLKEYL 104
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 28/119 (23%), Positives = 54/119 (45%), Gaps = 12/119 (10%)
Query: 273 FDVNDQYDPE-VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAV 330
FD+ QY P+ V + H ++ LG G FG+V++ + G A
Sbjct: 31 FDIWKQYYPQPVEIKH---------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 81
Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
K + + + E + E++T+S+ H L+ L +NE +++Y +M G + ++
Sbjct: 82 KFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 139
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 28/119 (23%), Positives = 54/119 (45%), Gaps = 12/119 (10%)
Query: 273 FDVNDQYDPE-VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAV 330
FD+ QY P+ V + H ++ LG G FG+V++ + G A
Sbjct: 137 FDIWKQYYPQPVEIKH---------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
K + + + E + E++T+S+ H L+ L +NE +++Y +M G + ++
Sbjct: 188 KFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRA 134
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 35.0 bits (79), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 35.0 bits (79), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 74 -EEPIXIVTEYMSKGSLLDFLKG 95
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 84 -EEPIYIVIEYMSKGSLLDFLKG 105
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 77 -EEPIYIVTEYMSKGSLLDFLKG 98
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 84 -EEPIYIVTEYMSKGSLLDFLKG 105
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 84 -EEPIYIVIEYMSKGSLLDFLKG 105
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 75 -EEPIYIVTEYMSKGSLLDFLKG 96
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 35.0 bits (79), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 250 -EEPIYIVTEYMSKGSLLDFLKG 271
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 35.0 bits (79), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 84 -EEPIYIVTEYMSKGSLLDFLKG 105
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 35.0 bits (79), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 73 -EEPIYIVTEYMSKGSLLDFLKG 94
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 35.0 bits (79), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 333 -EEPIYIVTEYMSKGSLLDFLKG 354
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 35.0 bits (79), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 4/89 (4%)
Query: 306 KNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+ ++G G FG V G VA+K LK F +E + H N++
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G + +++ +M NGS+ S LR
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLR 100
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 35.0 bits (79), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 19/120 (15%)
Query: 280 DPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLK 334
DP + FKE + +LG G FG V+KG + S V +K ++
Sbjct: 15 DPSEKANKVLARIFKE-----TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE 69
Query: 335 DYNIAGGEVQFQTEVETISLAV----HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
D + G FQ + + LA+ H +++RL G C + + LV Y+P GS+ +R
Sbjct: 70 DKS---GRQSFQAVTDHM-LAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR 124
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 35.0 bits (79), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 250 -EEPIYIVTEYMSKGSLLDFLKG 271
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 3/93 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNIA--GGEVQFQTEVETISLAVH 357
+F LG+G FG VY + A+K L + G E Q + E+E S H
Sbjct: 15 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N+LR+ + L+ + P G + L+
Sbjct: 75 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ 107
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 84 -EEPIYIVTEYMSKGSLLDFLKG 105
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 34.7 bits (78), Expect = 0.087, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRA 134
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 34.7 bits (78), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 3/93 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNIA--GGEVQFQTEVETISLAVH 357
+F LG+G FG VY + A+K L + G E Q + E+E S H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N+LR+ + L+ + P G + L+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ 106
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 34.7 bits (78), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 3/93 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNIA--GGEVQFQTEVETISLAVH 357
+F LG+G FG VY + A+K L + G E Q + E+E S H
Sbjct: 14 DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
N+LR+ + L+ + P G + L+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ 106
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 34.7 bits (78), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 81 -EEPIYIVTEYMNKGSLLDFLKG 102
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 81 -EEPIYIVTEYMNKGSLLDFLKG 102
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 180
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 84 -EEPIYIVCEYMSKGSLLDFLKG 105
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 19/107 (17%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQT 347
FKE + +LG G FG V+KG + S V +K ++D + G FQ
Sbjct: 10 FKE-----TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQA 61
Query: 348 EVETISLAV----HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ + LA+ H +++RL G C + + LV Y+P GS+ +R
Sbjct: 62 VTDHM-LAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR 106
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 126
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 123
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM GS+ L+G
Sbjct: 250 -EEPIYIVGEYMSKGSLLDFLKG 271
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRG 391
++ L G C+ + ++ Y G++ LR
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 121
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
A + ILG G FG VY+G ++ + VAVK K + +F +E +
Sbjct: 6 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 355 AVHRNLLRLCGFCSTENERLLV--YPYMPNGSVASR 388
H ++++L G E +++ YPY G R
Sbjct: 66 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLER 101
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFC 367
LGRG FGIV++ + + + + G +V + E+ +++A HRN+L L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 368 STENERLLVYPYMPNGSVASRL 389
+ E ++++ ++ + R+
Sbjct: 71 ESMEELVMIFEFISGLDIFERI 92
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
A + ILG G FG VY+G ++ + VAVK K + +F +E +
Sbjct: 22 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 355 AVHRNLLRLCGFCSTENERLLV--YPYMPNGSVASR 388
H ++++L G E +++ YPY G R
Sbjct: 82 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLER 117
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
A + ILG G FG VY+G ++ + VAVK K + +F +E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 355 AVHRNLLRLCGFCSTENERLLV--YPYMPNGSVASR 388
H ++++L G E +++ YPY G R
Sbjct: 70 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLER 105
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +L G FG VYKG + +G VA+K L++ + E ++
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L++ MP G + +R
Sbjct: 82 DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVR 115
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G G V+ G ++ VAVK LK +++ F E + H+ L+RL
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLR 390
T+ ++ YM NGS+ L+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK 99
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +L G FG VYKG + +G VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 108
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + +G VA+ L++ + E ++
Sbjct: 49 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 142
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 40/93 (43%), Gaps = 3/93 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAVH 357
+F N+LG+G F VY+ G VA+K + K G VQ Q EV+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
++L L + N LV NG + L+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK 103
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +L G FG VYKG + +G VA+K L++ + E ++
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ ++ RL G C T +L+ MP G + +R
Sbjct: 82 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR 115
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 33.1 bits (74), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGG 341
G R +E+ A S + I+G G G V G VA+K LK
Sbjct: 36 GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F +E + H N++RL G + ++V YM NGS+ + LR
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 33.1 bits (74), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM G + L+G
Sbjct: 84 -EEPIYIVMEYMSKGCLLDFLKG 105
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 33.1 bits (74), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGG 341
G R +E+ A S + I+G G G V G VA+K LK
Sbjct: 36 GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F +E + H N++RL G + ++V YM NGS+ + LR
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 15/65 (23%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
+S+F K++LG G +G+V G +VA+K+++ ++ ++ E++ + H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 359 NLLRL 363
N++ +
Sbjct: 70 NIITI 74
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 18/77 (23%), Positives = 36/77 (46%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG VYK + +++A ++ D + E++ ++ H N+++L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 369 TENERLLVYPYMPNGSV 385
EN ++ + G+V
Sbjct: 105 YENNLWILIEFCAGGAV 121
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 15/65 (23%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
+S+F K++LG G +G+V G +VA+K+++ ++ ++ E++ + H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 359 NLLRL 363
N++ +
Sbjct: 70 NIITI 74
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 18/77 (23%), Positives = 36/77 (46%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG VYK + +++A ++ D + E++ ++ H N+++L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 369 TENERLLVYPYMPNGSV 385
EN ++ + G+V
Sbjct: 105 YENNLWILIEFCAGGAV 121
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 15/65 (23%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
+S+F K++LG G +G+V G +VA+K+++ ++ ++ E++ + H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 359 NLLRL 363
N++ +
Sbjct: 70 NIITI 74
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 8/107 (7%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGE 342
K+ KE+ + F + LG FG VYKG VA+K LKD
Sbjct: 16 KQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 73
Query: 343 VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+F+ E + H N++ L G + + +++ Y +G + L
Sbjct: 74 EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 33.1 bits (74), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 18/77 (23%), Positives = 36/77 (46%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG VYK + +++A ++ D + E++ ++ H N+++L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 369 TENERLLVYPYMPNGSV 385
EN ++ + G+V
Sbjct: 105 YENNLWILIEFCAGGAV 121
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 33.1 bits (74), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRG 391
E +V YM G + L+G
Sbjct: 84 -EEPIYIVTEYMSKGCLLDFLKG 105
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 32.7 bits (73), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 28/113 (24%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 291 YTFKELRAATSNFSAK---------NILGRGGFGIVYKGCFS----DGALVAVKRLKDYN 337
+TF++ A F+ + ++G G FG V G VA+K LK
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
F +E + H N++ L G + +++ YM NGS+ + LR
Sbjct: 70 TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR 122
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 20/57 (35%), Positives = 30/57 (52%), Gaps = 2/57 (3%)
Query: 309 LGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRL 363
+GRG F VYKG ++ + VA L+D + E Q F+ E E + H N++R
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors A29
Length = 270
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 47/143 (32%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 54 NWDITSVDPCSWRMITCSPDGY---VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAI 110
N + SVD CS + +T P L L S LS S LTKL+ + L +N
Sbjct: 15 NNNKNSVD-CSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK- 72
Query: 111 LGPIPASLGK-LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCP----ES 165
L +PA + K L+ L+TL +++NK +P + D S P +S
Sbjct: 73 LQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS 131
Query: 166 LSKIESLTLVDLSYNNLSGSLPK 188
L+K LT + L YN L SLPK
Sbjct: 132 LTK---LTYLSLGYNELQ-SLPK 150
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 32.3 bits (72), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 1/88 (1%)
Query: 303 FSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
F K LG G F +V + G L AVK + + G E + E+ + H N++
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRL 389
L + N LV + G + R+
Sbjct: 84 ALEDIYESPNHLYLVMQLVSGGELFDRI 111
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 32.3 bits (72), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
+N LG G FG V + D L VAVK LK A + +E++ +S
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L H N++ L G C+ L++ Y G + + LR
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 127
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++F +GRGGFG+V++ D A+KR++ N + EV+ ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 360 LLR 362
++R
Sbjct: 66 IVR 68
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
+N LG G FG V + D L VAVK LK A + +E++ +S
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L H N++ L G C+ L++ Y G + + LR
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 32.0 bits (71), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 31/96 (32%), Positives = 38/96 (39%), Gaps = 12/96 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTE--VETISLAVHR 358
N ++GRG +G VYKG D VAVK N F E + + L H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHD 67
Query: 359 NLLRLC-----GFCSTENERLLVYPYMPNGSVASRL 389
N+ R E LLV Y PNGS+ L
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
+N LG G FG V + D L VAVK LK A + +E++ +S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L H N++ L G C+ L++ Y G + + LR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 32.0 bits (71), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
+N LG G FG V + D L VAVK LK A + +E++ +S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L H N++ L G C+ L++ Y G + + LR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 18/63 (28%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++F LGRGGFG+V++ D A+KR++ N + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 360 LLR 362
++R
Sbjct: 65 IVR 67
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE--SFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 369 TENERLLVYPYMPNGSVASRLR 390
E +V YM GS+ L+
Sbjct: 75 -EEPIYIVTEYMNKGSLLDFLK 95
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 32.0 bits (71), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 9/136 (6%)
Query: 264 RYRHNQQI-FFDVNDQYDPEVSLGHLKRYTFK-ELRAATSNFSAKNILGRGGFGIVYK-- 319
++R+ Q+ V D E + Y + + N +LG G FG V
Sbjct: 6 QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNAT 65
Query: 320 --GCFSDGA--LVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLLRLCGFCSTENERL 374
G G VAVK LK+ + +E++ ++ L H N++ L G C+
Sbjct: 66 AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125
Query: 375 LVYPYMPNGSVASRLR 390
L++ Y G + + LR
Sbjct: 126 LIFEYCCYGDLLNYLR 141
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
+N LG G FG V + D L VAVK LK A + +E++ +S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L H N++ L G C+ L++ Y G + + LR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
+N LG G FG V + D L VAVK LK A + +E++ +S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
L H N++ L G C+ L++ Y G + + LR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 32.0 bits (71), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 23/74 (31%), Positives = 34/74 (45%), Gaps = 3/74 (4%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG G + VYKG +D LVA+K ++ + G EV + H N++ L
Sbjct: 10 LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 367 CSTENERLLVYPYM 380
TE LV+ Y+
Sbjct: 69 IHTEKSLTLVFEYL 82
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 32.0 bits (71), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 307 NILGRGGFGIVYKGCF-SDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+LG G FG VYKG + DG VA+K L++ + E ++ +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
RL G C T + LV MP G + +R
Sbjct: 83 RLLGICLTSTVQ-LVTQLMPYGCLLDHVR 110
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 32.0 bits (71), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 28/101 (27%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KE+ A S + ++G G FG V G VA+K LK F +E
Sbjct: 3 KEIDA--SCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++ L G + +++ YM NGS+ + LR
Sbjct: 61 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR 101
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 28/101 (27%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KE+ A S + + ++G G FG V G VA+K LK F E
Sbjct: 17 KEIEA--SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++ L G + ++V YM NGS+ + L+
Sbjct: 75 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK 115
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 39/78 (50%), Gaps = 2/78 (2%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G FG VYK + GAL A K ++ + E + E+E ++ H +++L G
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 77
Query: 368 STENERLLVYPYMPNGSV 385
+ + ++ + P G+V
Sbjct: 78 YHDGKLWIMIEFCPGGAV 95
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 31.6 bits (70), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 44/105 (41%), Gaps = 6/105 (5%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQF 345
R KE+ A S + ++G G FG V G VA+K LK F
Sbjct: 5 REFAKEIDA--SCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+E + H N++ L G + +++ YM NGS+ + LR
Sbjct: 63 LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR 107
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 31.6 bits (70), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 31.6 bits (70), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRLKDYNI-AGGEVQFQTEVET 351
+A S+F +LG+G FG V+ K D G L A+K LK + V+ + E +
Sbjct: 24 KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
++ H +++L TE + L+ ++ G + +RL
Sbjct: 84 LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL 121
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 31.6 bits (70), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 49 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 31.6 bits (70), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 39/78 (50%), Gaps = 2/78 (2%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G FG VYK + GAL A K ++ + E + E+E ++ H +++L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 368 STENERLLVYPYMPNGSV 385
+ + ++ + P G+V
Sbjct: 86 YHDGKLWIMIEFCPGGAV 103
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 31.6 bits (70), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 31.6 bits (70), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 31.6 bits (70), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 31.6 bits (70), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 31.6 bits (70), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 31.6 bits (70), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 31.6 bits (70), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 31.6 bits (70), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 31.6 bits (70), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 44 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 31.6 bits (70), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 16 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 31.6 bits (70), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 42/103 (40%), Gaps = 8/103 (7%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQ 346
KE+ + F + LG FG VYKG VA+K LKD +F+
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
E + H N++ L G + + +++ Y +G + L
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 103
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 31.2 bits (69), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
KE S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 48
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 31.2 bits (69), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
KE S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 23 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 70
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 31.2 bits (69), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
KE S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 48
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 31.2 bits (69), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 16 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 31.2 bits (69), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 31.2 bits (69), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 31.2 bits (69), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 44 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 31.2 bits (69), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 18/76 (23%), Positives = 38/76 (50%), Gaps = 7/76 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+G G +G+VYK + G A+K+++ D I ++ E+ + H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 365 GFCSTENERLLVYPYM 380
T+ +LV+ ++
Sbjct: 67 DVIHTKKRLVLVFEHL 82
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 31.2 bits (69), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
KE S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 48
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 31.2 bits (69), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 24/47 (51%), Gaps = 1/47 (2%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
KE S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 1 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 47
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 31.2 bits (69), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 18/76 (23%), Positives = 38/76 (50%), Gaps = 7/76 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+G G +G+VYK + G A+K+++ D I ++ E+ + H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 365 GFCSTENERLLVYPYM 380
T+ +LV+ ++
Sbjct: 67 DVIHTKKRLVLVFEHL 82
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 31.2 bits (69), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEV 349
KE S + +LG GGFG VY G SD VA+K ++ I+ GE+ T V
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 31.2 bits (69), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 18/76 (23%), Positives = 38/76 (50%), Gaps = 7/76 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+G G +G+VYK + G A+K+++ D I ++ E+ + H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 365 GFCSTENERLLVYPYM 380
T+ +LV+ ++
Sbjct: 67 DVIHTKKRLVLVFEHL 82
>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 520
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 43/89 (48%), Gaps = 5/89 (5%)
Query: 49 YNVLENWDITSVDPCSWRMITCSPDGYVS---ALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
Y + N +I + RM+ +S L + L+ T+ G+LT+L++++L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 106 QNNAI--LGPIPASLGKLEKLQTLDLSNN 132
Q N + L I +++ LQ LD+S N
Sbjct: 356 QMNQLKELSKIAEMTTQMKSLQQLDISQN 384
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 24/47 (51%), Gaps = 1/47 (2%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
KE S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 1 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 47
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 11/98 (11%)
Query: 297 RAATSNF-SAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVET 351
R A S+F ++ LGRG IVY KG AL +K+ D I +TE+
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV------RTEIGV 101
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+ H N+++L T E LV + G + R+
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI 139
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/84 (25%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+LG+G +GIVY G S+ +A+K + + + + E+ H+N+++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 367 CSTENERLLVYPYMPNGSVASRLR 390
S + +P GS+++ LR
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLR 111
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 6/65 (9%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+F ++G GGFG V+K DG +KR+K YN E EV+ ++ H N+
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAE----REVKALAKLDHVNI 66
Query: 361 LRLCG 365
+ G
Sbjct: 67 VHYNG 71
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/84 (25%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+LG+G +GIVY G S+ +A+K + + + + E+ H+N+++ G
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 73
Query: 367 CSTENERLLVYPYMPNGSVASRLR 390
S + +P GS+++ LR
Sbjct: 74 FSENGFIKIFMEQVPGGSLSALLR 97
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
LG G FG V Y SD A+ VAVK LK +E++ +S L H N++
Sbjct: 47 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C+ L++ Y G + + LR
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLR 135
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI 338
++FS I+GRGGFG VY GC G + A+K L I
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRI 227
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI 338
++FS I+GRGGFG VY GC G + A+K L I
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRI 227
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI 338
++FS I+GRGGFG VY GC G + A+K L I
Sbjct: 188 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRI 226
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI 338
++FS I+GRGGFG VY GC G + A+K L I
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRI 227
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
LG G FG V Y SD A+ VAVK LK +E++ +S L H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C+ L++ Y G + + LR
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLR 119
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
LG G FG V Y SD A+ VAVK LK +E++ +S L H N++
Sbjct: 49 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C+ L++ Y G + + LR
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLR 137
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
LG G FG V Y SD A+ VAVK LK +E++ +S L H N++
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C+ L++ Y G + + LR
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLR 142
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
LG G FG V Y SD A+ VAVK LK +E++ +S L H N++
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLR 390
L G C+ L++ Y G + + LR
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLR 142
>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1
pdb|1XEC|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 2
pdb|1XEC|B Chain B, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 2
Length = 329
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 11/90 (12%)
Query: 63 CSWRMITCSPDGY----------VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG 112
C R++ CS G + L L + ++ NL L +++L NN I
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 113 PIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
P + L KL+ L LS N+ E+P+ +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM 119
>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin,
The Archetypal Small Leucine-Rich Repeat Proteoglycan
Length = 330
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 11/90 (12%)
Query: 63 CSWRMITCSPDGY----------VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG 112
C R++ CS G + L L + ++ NL L +++L NN I
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 113 PIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
P + L KL+ L LS N+ E+P+ +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM 119
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRL-KDYNIAGGEVQ-FQTEVETIS 353
R NF +LG+G FG V + G L AVK L KD + +V+ TE +S
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
LA + L C +RL NG
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 368 STENERLLVYPYMPNGSVASRLR 390
ST+ + +V + S+ L
Sbjct: 73 STKPQLAIVTQWCEGSSLYHHLH 95
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 368 STENERLLVYPYMPNGSVASRLR 390
ST+ + +V + S+ L
Sbjct: 78 STKPQLAIVTQWCEGSSLYHHLH 100
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 23/44 (52%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL 333
R EL A S ++ + + G +G V G S+G VA+KR+
Sbjct: 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV 54
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 20/72 (27%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHR 358
S + +G+G FG V+K G VA+K+ L + G + E++ + L H
Sbjct: 18 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 359 NLLRLCGFCSTE 370
N++ L C T+
Sbjct: 78 NVVNLIEICRTK 89
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 18 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 368 STENERLLVYPYMPNGSVASRLR 390
ST+ + +V + S+ L
Sbjct: 75 STKPQLAIVTQWCEGSSLYHHLH 97
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 368 STENERLLVYPYMPNGSVASRLR 390
ST+ + +V + S+ L
Sbjct: 73 STKPQLAIVTQWCEGSSLYHHLH 95
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 23/44 (52%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL 333
R EL A S ++ + + G +G V G S+G VA+KR+
Sbjct: 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV 54
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 2/73 (2%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISLAVH 357
S + +G+G FG V+K G VA+K+ L + G + E++ + L H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 358 RNLLRLCGFCSTE 370
N++ L C T+
Sbjct: 76 ENVVNLIEICRTK 88
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 368 STENERLLVYPYMPNGSVASRLR 390
ST+ + +V + S+ L
Sbjct: 78 STKPQLAIVTQWCEGSSLYHHLH 100
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 6/101 (5%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
KEL A S + ++G G FG V G VA+K LK F E
Sbjct: 38 KELDA--SCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
+ H N++ L G + ++V +M NG++ + LR
Sbjct: 96 SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR 136
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 2/73 (2%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISLAVH 357
S + +G+G FG V+K G VA+K+ L + G + E++ + L H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 358 RNLLRLCGFCSTE 370
N++ L C T+
Sbjct: 77 ENVVNLIEICRTK 89
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 2/73 (2%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISLAVH 357
S + +G+G FG V+K G VA+K+ L + G + E++ + L H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 358 RNLLRLCGFCSTE 370
N++ L C T+
Sbjct: 77 ENVVNLIEICRTK 89
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 368 S 368
+
Sbjct: 74 T 74
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 30.0 bits (66), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 20/83 (24%), Positives = 38/83 (45%), Gaps = 13/83 (15%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
++G G FG+V++ + VA+K+ L+D E+Q + + H N++ L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI------MRIVKHPNVVDLKA 99
Query: 366 FCSTENERL------LVYPYMPN 382
F + ++ LV Y+P
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE 122
>pdb|2Z80|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
pdb|2Z80|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 353
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 111 LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIE 170
L IP+ G E +++LDLSNN+ T L +S S +
Sbjct: 43 LNSIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100
Query: 171 SLTLVDLSYN---NLSGSLPK-ISARTF-KVTGNP 200
SL +DLSYN NLS S K +S+ TF + GNP
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP 135
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 43 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 368 S 368
+
Sbjct: 101 T 101
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 36 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 368 S 368
+
Sbjct: 94 T 94
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSDG-ALVAVKRLKDYNI-AGGEVQFQTEVET 351
+A S F +LG+G FG V+ K SD L A+K LK + V+ + E +
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+ H +++L TE + L+ ++ G + +RL
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 117
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 18/80 (22%), Positives = 37/80 (46%), Gaps = 1/80 (1%)
Query: 307 NILGR-GGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
I+G G FG VYK + +++A ++ D + E++ ++ H N+++L
Sbjct: 15 EIIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 74
Query: 366 FCSTENERLLVYPYMPNGSV 385
EN ++ + G+V
Sbjct: 75 AFYYENNLWILIEFCAGGAV 94
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 368 S 368
+
Sbjct: 102 T 102
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 368 S 368
+
Sbjct: 102 T 102
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 20 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 368 S 368
+
Sbjct: 78 T 78
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSDG-ALVAVKRLKDYNI-AGGEVQFQTEVET 351
+A S F +LG+G FG V+ K SD L A+K LK + V+ + E +
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+ H +++L TE + L+ ++ G + +RL
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 117
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 29.6 bits (65), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSDG-ALVAVKRLKDYNI-AGGEVQFQTEVET 351
+A S F +LG+G FG V+ K SD L A+K LK + V+ + E +
Sbjct: 21 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
+ H +++L TE + L+ ++ G + +RL
Sbjct: 81 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 118
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 368 S 368
+
Sbjct: 90 T 90
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 3/61 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 368 S 368
+
Sbjct: 90 T 90
>pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 549
Score = 29.6 bits (65), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 111 LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIE 170
L IP+ G E +++LDLSNN+ T L +S S +
Sbjct: 17 LNSIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 74
Query: 171 SLTLVDLSYN---NLSGSLPK-ISARTF-KVTGNP 200
SL +DLSYN NLS S K +S+ TF + GNP
Sbjct: 75 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP 109
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 29.3 bits (64), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
++ +N +GRG +G V K G + A K++ Y + + +F+ E+E + H N+
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNI 68
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRL 389
+RL + LV G + R+
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERV 97
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 29.3 bits (64), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 2/109 (1%)
Query: 284 SLGHLKRYTFKELRAATSN-FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG 341
S+ HL+ + + R F+ + +G+G FG VYKG + +VA+K +
Sbjct: 1 SMAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDE 60
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
Q E+ +S + R G + ++ Y+ GS L+
Sbjct: 61 IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK 109
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 29.3 bits (64), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 304 SAKNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
+ ++G+G FG+VY G + D A A+K L F E + H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 360 LLRLCG-FCSTENERLLVYPYMPNGSVASRLR 390
+L L G E ++ PYM +G + +R
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR 115
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 29.3 bits (64), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 17/46 (36%), Positives = 23/46 (50%), Gaps = 1/46 (2%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
E S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 1 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 46
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 29.3 bits (64), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
++ +N +GRG +G V K G + A K++ Y + + +F+ E+E + H N+
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNI 85
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRL 389
+RL + LV G + R+
Sbjct: 86 IRLYETFEDNTDIYLVMELCTGGELFERV 114
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 28.9 bits (63), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 1/40 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 43
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 1/40 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 43
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 1/40 (2%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIA 339
S + +LG GGFG VY G SD VA+K ++ I+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 43
>pdb|2V9S|A Chain A, Second Lrr Domain Of Human Slit2
pdb|2V9S|B Chain B, Second Lrr Domain Of Human Slit2
pdb|2V9S|C Chain C, Second Lrr Domain Of Human Slit2
pdb|2V9S|D Chain D, Second Lrr Domain Of Human Slit2
Length = 220
Score = 28.5 bits (62), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 49/122 (40%), Gaps = 11/122 (9%)
Query: 88 GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXX 147
G SP+ KL+ + L NN I P + L L +L L NK T E+P SL +
Sbjct: 50 GAFSPY----KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLF 104
Query: 148 XXXXXXXXXXXTGSCP-ESLSKIESLTLVDLSYNNLS----GSLPKISA-RTFKVTGNPL 201
++ + +L L+ L N L G+ + A +T + NP
Sbjct: 105 SLQLLLLNANKINXLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
Query: 202 IC 203
IC
Sbjct: 165 IC 166
>pdb|2V9T|B Chain B, Complex Between The Second Lrr Domain Of Slit2 And The
First Ig Domain From Robo1
Length = 220
Score = 28.5 bits (62), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 49/122 (40%), Gaps = 11/122 (9%)
Query: 88 GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXX 147
G SP+ KL+ + L NN I P + L L +L L NK T E+P SL +
Sbjct: 50 GAFSPY----KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLF 104
Query: 148 XXXXXXXXXXXTGSCP-ESLSKIESLTLVDLSYNNLS----GSLPKISA-RTFKVTGNPL 201
++ + +L L+ L N L G+ + A +T + NP
Sbjct: 105 SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
Query: 202 IC 203
IC
Sbjct: 165 IC 166
>pdb|3EE1|A Chain A, Novel Fold Of Vira, A Type Iii Secretion System Effector
Protein From Shigella Flexneri
pdb|3EE1|B Chain B, Novel Fold Of Vira, A Type Iii Secretion System Effector
Protein From Shigella Flexneri
Length = 400
Score = 28.1 bits (61), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 23/68 (33%), Positives = 28/68 (41%), Gaps = 13/68 (19%)
Query: 168 KIESLTLVDLSYNNLSGSLP-------KISARTFKVTGNPLICGP------KATNNCTAV 214
KI+S L YNNL SLP K+ T V+GN P A N CT++
Sbjct: 106 KIQSTQLSSKEYNNLLSSLPPKQFNLGKVHTITAPVSGNFKTHKPAPEVIETAINCCTSI 165
Query: 215 FPEPLSLP 222
P P
Sbjct: 166 IPNDDYFP 173
>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
pdb|3RFS|B Chain B, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
Length = 272
Score = 28.1 bits (61), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 42/96 (43%), Gaps = 3/96 (3%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXX 153
+ LT L ++L N + KL L+ L L N+ +PD + D
Sbjct: 81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLN 139
Query: 154 XXXXXTGSCPESL-SKIESLTLVDLSYNNLSGSLPK 188
S P+ + K+ +LT +DLSYN L SLP+
Sbjct: 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
>pdb|3EB8|A Chain A, Vira
pdb|3EB8|B Chain B, Vira
Length = 358
Score = 28.1 bits (61), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 27/62 (43%), Gaps = 13/62 (20%)
Query: 168 KIESLTLVDLSYNNLSGSLP-------KISARTFKVTGNPLICGP------KATNNCTAV 214
KI+S L YNNL SLP K+ T V+GN P A N CT++
Sbjct: 64 KIQSTQLSSKEYNNLLSSLPPKQFNLGKVHTITAPVSGNFKTHKPAPEVIETAINCCTSI 123
Query: 215 FP 216
P
Sbjct: 124 IP 125
>pdb|4FMB|A Chain A, Vira-Rab1 Complex Structure
pdb|4FMB|C Chain C, Vira-Rab1 Complex Structure
pdb|4FMB|E Chain E, Vira-Rab1 Complex Structure
Length = 361
Score = 28.1 bits (61), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 27/62 (43%), Gaps = 13/62 (20%)
Query: 168 KIESLTLVDLSYNNLSGSLP-------KISARTFKVTGNPLICGP------KATNNCTAV 214
KI+S L YNNL SLP K+ T V+GN P A N CT++
Sbjct: 67 KIQSTQLSSKEYNNLLSSLPPKQFNLGKVHTITAPVSGNFKTHKPAPEVIETAINCCTSI 126
Query: 215 FP 216
P
Sbjct: 127 IP 128
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.137 0.412
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 11,398,309
Number of Sequences: 62578
Number of extensions: 453510
Number of successful extensions: 1884
Number of sequences better than 100.0: 496
Number of HSP's better than 100.0 without gapping: 113
Number of HSP's successfully gapped in prelim test: 383
Number of HSP's that attempted gapping in prelim test: 1504
Number of HSP's gapped (non-prelim): 573
length of query: 391
length of database: 14,973,337
effective HSP length: 101
effective length of query: 290
effective length of database: 8,652,959
effective search space: 2509358110
effective search space used: 2509358110
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)